Medibio names medical-device veteran Kaysen CEO
Medibio Ltd., which develops technology that aims to diagnose mental-health conditions, has named medical-device industry veteran David Kaysen its CEO and managing director.
Kaysen was most recently CEO of a Sun BioPharma Inc., a biotech company developing drugs to treat diseases affecting the pancreas. He was previously the top executive at medical-device maker Uroplasty Inc., which makes devices that treated overactive bladder and incontinence. (He's also the father of renowned Minneapolis chef…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Katharine Grayson Source Type: news
More News: Biotechnology | Health Management | Incontinence | Medical Devices | Men | Overactive Bladder | Overactive Bladder Syndrome | Pancreas | Pharmaceuticals